DIVIS LABORATORIES
|
DIVIS LABORATORIES Last 5 Year Balance Sheet History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹53 Cr | ₹53 Cr | ₹53 Cr | ₹53 Cr | ₹53 Cr |
Equity - Authorised | ₹60 Cr | ₹60 Cr | ₹60 Cr | ₹60 Cr | ₹60 Cr |
Equity - Issued | ₹53 Cr | ₹53 Cr | ₹53 Cr | ₹53 Cr | ₹53 Cr |
Equity Paid Up | ₹53 Cr | ₹53 Cr | ₹53 Cr | ₹53 Cr | ₹53 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 |
Share Warrants & Outstandings | - | - | - | - | - |
Total Reserves | ₹13,518 Cr | ₹12,714 Cr | ₹11,675 Cr | ₹9,242 Cr | ₹7,257 Cr |
Securities Premium | ₹80 Cr | ₹80 Cr | ₹80 Cr | ₹80 Cr | ₹80 Cr |
Capital Reserves | - | - | - | - | - |
Profit & Loss Account Balance | ₹11,786 Cr | ₹10,959 Cr | ₹9,989 Cr | ₹7,598 Cr | ₹5,794 Cr |
General Reserves | ₹1,000 Cr | ₹1,000 Cr | ₹1,000 Cr | ₹1,000 Cr | ₹1,000 Cr |
Other Reserves | ₹652 Cr | ₹675 Cr | ₹606 Cr | ₹564 Cr | ₹383 Cr |
Reserve excluding Revaluation Reserve | ₹13,518 Cr | ₹12,714 Cr | ₹11,675 Cr | ₹9,242 Cr | ₹7,257 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹13,571 Cr | ₹12,767 Cr | ₹11,728 Cr | ₹9,295 Cr | ₹7,310 Cr |
Minority Interest | - | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | - | - | - | - | - |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | - | - | - | - | - |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | - | - | - | - | - |
Unsecured Loans | - | - | - | - | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹572 Cr | ₹523 Cr | ₹407 Cr | ₹335 Cr | ₹270 Cr |
Deferred Tax Assets | ₹30 Cr | ₹31 Cr | ₹36 Cr | ₹16 Cr | ₹15 Cr |
Deferred Tax Liability | ₹602 Cr | ₹554 Cr | ₹443 Cr | ₹351 Cr | ₹284 Cr |
Other Long Term Liabilities | ₹2.00 Cr | ₹3.00 Cr | ₹2.87 Cr | ₹3.69 Cr | ₹4.47 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹37 Cr | ₹31 Cr | ₹27 Cr | ₹25 Cr | ₹21 Cr |
Total Non-Current Liabilities | ₹611 Cr | ₹557 Cr | ₹437 Cr | ₹364 Cr | ₹295 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹824 Cr | ₹762 Cr | ₹796 Cr | ₹763 Cr | ₹591 Cr |
Sundry Creditors | ₹824 Cr | ₹762 Cr | ₹796 Cr | ₹763 Cr | ₹591 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹404 Cr | ₹332 Cr | ₹394 Cr | ₹340 Cr | ₹290 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹34 Cr | ₹33 Cr | ₹17 Cr | ₹16 Cr | ₹29 Cr |
Interest Accrued But Not Due | - | - | - | - | - |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹370 Cr | ₹299 Cr | ₹377 Cr | ₹324 Cr | ₹261 Cr |
Short Term Borrowings | - | - | - | ₹0.35 Cr | ₹34 Cr |
Secured ST Loans repayable on Demands | - | - | - | ₹0.35 Cr | ₹34 Cr |
Working Capital Loans- Sec | - | - | - | ₹0.35 Cr | ₹34 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | - | - | - | ₹-0.35 Cr | ₹-34 Cr |
Short Term Provisions | ₹527 Cr | ₹445 Cr | ₹1,265 Cr | ₹624 Cr | ₹906 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹520 Cr | ₹440 Cr | ₹1,261 Cr | ₹622 Cr | ₹904 Cr |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹7.00 Cr | ₹5.00 Cr | ₹4.15 Cr | ₹2.51 Cr | ₹2.46 Cr |
Total Current Liabilities | ₹1,755 Cr | ₹1,539 Cr | ₹2,454 Cr | ₹1,728 Cr | ₹1,821 Cr |
Total Liabilities | ₹15,937 Cr | ₹14,863 Cr | ₹14,619 Cr | ₹11,387 Cr | ₹9,425 Cr |
ASSETS | |||||
Gross Block | ₹6,760 Cr | ₹6,365 Cr | ₹5,624 Cr | ₹4,692 Cr | ₹3,514 Cr |
Less: Accumulated Depreciation | ₹2,021 Cr | ₹1,643 Cr | ₹1,299 Cr | ₹988 Cr | ₹732 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹4,739 Cr | ₹4,722 Cr | ₹4,325 Cr | ₹3,704 Cr | ₹2,782 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹778 Cr | ₹212 Cr | ₹470 Cr | ₹711 Cr | ₹920 Cr |
Non Current Investments | ₹82 Cr | ₹77 Cr | ₹72 Cr | ₹0.01 Cr | ₹0.01 Cr |
Long Term Investment | ₹82 Cr | ₹77 Cr | ₹72 Cr | ₹0.01 Cr | ₹0.01 Cr |
Quoted | - | - | - | - | - |
Unquoted | ₹82 Cr | ₹77 Cr | ₹72 Cr | ₹0.01 Cr | ₹0.01 Cr |
Long Term Loans & Advances | ₹176 Cr | ₹97 Cr | ₹134 Cr | ₹173 Cr | ₹145 Cr |
Other Non Current Assets | ₹10.00 Cr | ₹5.00 Cr | ₹8.05 Cr | ₹9.21 Cr | ₹5.44 Cr |
Total Non-Current Assets | ₹5,785 Cr | ₹5,113 Cr | ₹5,009 Cr | ₹4,596 Cr | ₹3,851 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | - | - | - | - | ₹971 Cr |
Quoted | - | - | - | - | ₹971 Cr |
Unquoted | - | - | - | - | - |
Inventories | ₹3,184 Cr | ₹3,000 Cr | ₹2,829 Cr | ₹2,145 Cr | ₹1,864 Cr |
Raw Materials | ₹1,091 Cr | ₹972 Cr | ₹773 Cr | ₹706 Cr | ₹507 Cr |
Work-in Progress | ₹1,620 Cr | ₹1,526 Cr | ₹1,532 Cr | ₹1,093 Cr | ₹981 Cr |
Finished Goods | ₹150 Cr | ₹175 Cr | ₹154 Cr | ₹99 Cr | ₹64 Cr |
Packing Materials | ₹8.00 Cr | ₹9.00 Cr | ₹9.16 Cr | ₹8.38 Cr | ₹4.34 Cr |
Stores  and Spare | ₹148 Cr | ₹191 Cr | ₹196 Cr | ₹104 Cr | ₹104 Cr |
Other Inventory | ₹167 Cr | ₹127 Cr | ₹165 Cr | ₹134 Cr | ₹203 Cr |
Sundry Debtors | ₹2,156 Cr | ₹1,793 Cr | ₹2,424 Cr | ₹1,677 Cr | ₹1,413 Cr |
Debtors more than Six months | ₹18 Cr | ₹11 Cr | ₹10 Cr | ₹14 Cr | - |
Debtors Others | ₹2,148 Cr | ₹1,788 Cr | ₹2,419 Cr | ₹1,668 Cr | ₹1,427 Cr |
Cash and Bank | ₹3,980 Cr | ₹4,214 Cr | ₹2,819 Cr | ₹2,156 Cr | ₹123 Cr |
Cash in hand | ₹1.00 Cr | ₹1.00 Cr | ₹0.71 Cr | ₹0.75 Cr | ₹0.65 Cr |
Balances at Bank | ₹3,979 Cr | ₹4,213 Cr | ₹2,818 Cr | ₹2,155 Cr | ₹122 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹38 Cr | ₹28 Cr | ₹30 Cr | ₹52 Cr | ₹52 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹36 Cr | ₹26 Cr | ₹27 Cr | ₹23 Cr | ₹17 Cr |
Other current_assets | ₹2.00 Cr | ₹2.00 Cr | ₹2.60 Cr | ₹29 Cr | ₹35 Cr |
Short Term Loans and Advances | ₹794 Cr | ₹715 Cr | ₹1,509 Cr | ₹761 Cr | ₹1,150 Cr |
Advances recoverable in cash or in kind | ₹80 Cr | ₹34 Cr | ₹87 Cr | ₹31 Cr | ₹24 Cr |
Advance income tax and TDS | ₹505 Cr | ₹536 Cr | ₹1,317 Cr | ₹650 Cr | ₹973 Cr |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹209 Cr | ₹145 Cr | ₹105 Cr | ₹80 Cr | ₹154 Cr |
Total Current Assets | ₹10,152 Cr | ₹9,750 Cr | ₹9,610 Cr | ₹6,791 Cr | ₹5,574 Cr |
Net Current Assets (Including Current Investments) | ₹8,397 Cr | ₹8,211 Cr | ₹7,156 Cr | ₹5,062 Cr | ₹3,753 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹15,937 Cr | ₹14,863 Cr | ₹14,619 Cr | ₹11,387 Cr | ₹9,425 Cr |
Contingent Liabilities | ₹257 Cr | ₹89 Cr | ₹89 Cr | ₹7.06 Cr | ₹7.71 Cr |
Total Debt | - | - | - | ₹0.35 Cr | ₹34 Cr |
Book Value | 512.11 | 481.77 | 441.82 | 350.15 | 275.38 |
Adjusted Book Value | 512.11 | 481.77 | 441.82 | 350.15 | 275.38 |
Compare Balance Sheet of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹143,968.7 Cr | -0.5% | 6.4% | 44.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹457,025.0 Cr | -2% | 4.3% | 65.1% | Stock Analytics | |
CIPLA | ₹131,056.0 Cr | -2.9% | -1.8% | 39.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,731.0 Cr | -1.8% | -2.2% | 20.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹105,745.0 Cr | -1.6% | -6.3% | 73.8% | Stock Analytics | |
MANKIND PHARMA | ₹102,507.0 Cr | 0.7% | 8.1% | 41.1% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | -0.5% |
6.4% |
44.2% |
SENSEX | -5.3% |
-1.6% |
23.1% |
You may also like the below Video Courses